Here’s Why Elevance Health (ELV) Declined in Q4
Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | First Eagle Investment Management Jean-Marie Eveillard | 3,225,339 | $1,189,827,627 | +48% | 2.65% |
| 2. | Orbis Investment Management William B. Gray | 2,168,945 | $800,123,810 | +140% | 4.3% |
| 3. | Harris Associates Natixis Global Asset Management | 1,821,284 | $671,871,624 | 0.88% | |
| 4. | Brave Warrior Capital Glenn Greenberg | 1,629,977 | $601,298,515 | -1% | 14.96% |
| 5. | Eagle Capital Management Boykin Curry | 1,564,616 | $577,186,842 | -3% | 2.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $384.36 | 1,300 | Director | 4,714 | 2021-07-23 | Filing | |
| $296.03 | 1,700 | Director | 2,921 | 2021-02-04 | Filing | |
| $264.22 | 2,000 | Officer, Director | 26,556 | 2020-01-30 | Filing | |
| $263.52 | 5,600 | Officer, Director | 24,556 | 2020-01-30 | Filing | |
| $57.30 | 144 | Officer | 61,025 | 2010-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $415.13 | 443 | Officer | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | Officer | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | Officer | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | Director | 8,744 | 2024-08-05 | Filing | |
| $504.27 | 2,250 | Officer, Director | 126,709 | 2024-07-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,305 | $8,831,863 | 0.27% | |
| 2. | 5,309 | $2,309,203 | 0.08% | |
| 3. | 4,553 | $1,980,373 | 0.21% | |
| 4. | 1,280 | $556,620 | 0.06% | |
| 5. | 1,162 | $505,424 | 0.01% |
News See All
What Gives Elevance Health (ELV) an Attractive Opportunity in The Large Cap Space?
River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 investor letter. A copy of the letter can be downloaded here.
13 Best Healthcare Dividend Stocks to Invest in
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Elevance Health, Inc. (NYSE:ELV): Waning Industry Headwinds to Boost Performance
We came across a bullish thesis on Elevance Health, Inc. (NYSE:ELV) on ValueInvestorsClub by rhubarb. In this article, we will summarize the bulls’ thesis on ELV.
Top 10 Health Insurance Stocks To Buy
The health insurance industry is constantly changing, driven by a movement towards consumer-driven healthcare, in which people actively control their own health and healthcare costs.
Here’s Why Elevance Health (ELV) Traded Lower in Q4
Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why Elevance Health (ELV) Slid in Q4
GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the letter can be downloaded here.
12 Best Health Insurance Stocks to Buy in 2025
The health insurance sector in the US is currently experiencing significant shifts.
Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
15 Best Large-Cap Value Stocks to Buy in 2025
The market outlook is as uncertain as it gets.
Billionaire Hedge Funds
